+7 (495) 921-33-04
RU EN

Press

Chief Doctor

1/2012
86 DATES. EVENTS. PEOPLE

Zoom here Zoom here

Translated from Russian

THE PARTNERSHIP BETWEEN JOHNSON&JOHNSON AND BENTUS LABORATORIES WILL HELP REDUCE THE RATE OF OCCURRENCE OF NOSOCOMIAL INFECTIONS IN RUSSIAN CLINICS


On December 13 2011 OOO Johnson&Johnson and OOO Bentus Laboratories signed distribution agreement. Russian division of Advanced Sterilization Products company (ASP) owned by Johnson&Johnson which is the leading world developer of innovative technologies which help prevent nosocomial infections (NI) became the exclusive distributor of the professional line of products by Bentus Laboratories on the territory of the Russian Federation.

Bentus Laboratories specializes in the production of innovative skin antiseptics including disinfecting gels Sanitelle which are designed for professional and everyday hand sanitation. Being the sole distributor of Sanitelle Johnson & Johnson will increase its market share in professional hand treatment products by 15%. From the time when we established our offices in Russia which was more than 20 years ago we have been undertaking active steps to fight nosocomial infections both by using innovative products and solutions and by implementing the standards for preventing nosocomial infections in Russian hospitals, says Mr. Arman Voskerchyan, Director General of Johnson & Johnson in Russia and the CIS. . ASP division is one of the key suppliers of comprehensive solutions for the sterilization and the disinfection of advanced medical equipment and instruments. Now our supply offers will include products for medical specialists as well.

Johnson & Johnson is guided by the following criteria in the process of partner selection: the relevance of the products for the market, the compliance of production and product characteristics with international GMP standards, and the effectiveness of company management. Bentus Laboratories meets these criteria to full extent. Our partnership with the world leader in healthcare serves as the best evidence that both our products and the quality of our management and production processes comply with the highest international standards, comments Mr. Gaik Simonyan, Director General of OOO Bentus Laboratories.

This agreement with Johnson & Johnson sets up the new development options for OOO Bentus Laboratories. For example, we visualize a great potential for the sales of professional Sanitelle products both in Russia and abroad including the CIS and European countries, notes Mr. Rouben Simonian, President of Simonian & Associates Consulting, Inc. which provided strategic support of the transaction on behalf of OOO Bentus Laboratories.

Every year 50 to 60 thousand cases of nosocomial infections are reported in Russia. De facto this figure is 40-50 times larger. Experts estimate the economic losses from nosocomial infections in Russia at 5 billion Russian rubles. The strategic partnership between international company Johnson&Johnson and national company Bentus Laboratories specializing in the production of innovative skin sanitizers will definitely contribute to the solution of this pressing problem of Russian healthcare.

Back to the list